Clinical trial
Three Drug Combination Therapy Versus Conventional Treatment of Children With…
NCT00001521 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00001521 |
|---|---|
| Title | Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia |
| Official title | An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children With Congenital Adrenal Hyperplasia |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Congenital Adrenal Hyperplasia (CAH) |
| Intervention type | Drug |
| Interventions | Fludrocortisone, Hydrocortisone, Letrozole, Flutamide, Testolactone |
| Enrollment | 66 |
| Start date | Jun 8, 1995 |
| Primary completion | Apr 1, 2024 |
| Completion | Apr 1, 2024 |
| First posted | Nov 4, 1999 |
| Last update posted | Jun 12, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: